When it comes to the biotech space, multiple vendors are often involved in each drug launch milestone, requiring pharmaceutical manufacturers to manage multiple vendors with disparate data points. Healthcare services providers may promote themselves as viable manufacturer partners with specialty pharmaceutical expertise but often, they lack the in-depth understanding of the specialized needs of patients, physicians, payers, and disease state. The AscellaHealth Family of Companies is comprised of AscellaHealth and subsidiaries Optime Care and Terebellum. Optime Care, a leading specialty pharmacy and patient services management company, is focused on Life Sciences solutions for rare diseases and represents a single-source partner for pharmaceutical manufacturers, providing services from –pre-launch and launch through commercialization, distribution, fulfillment and beyond, offering a one-stop, consultative approach to enhanced access to medications, optimal cost-savings, and improved outcomes. “Our deep bench specialty and rare disease expertise provides additional insight into the unique challenges our clients face, enabling us to develop effective strategies for optimal medication access and enhanced outcomes and cost-savings,” states Dea Belazi, President and CEO, AscellaHealth.
To read more, click here.